Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Treatment for asthma and COPD exacerbations have not changed in 50 years despite causing 3.8 million deaths worldwide a year combined. "Benralizumab is a safe and effective drug already used to ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

Those suffering an “eosinophilic exacerbation” involving eosinophils (a type of white blood cell) were considered suitable for treatment. Around 50% of asthma attacks are eosinophilic ...

Emerging research suggests that certain diabetes medications could offer benefits beyond blood sugar control, potentially ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that gestational diabetes ...

PITTSBURGH (KDKA) - University of Pittsburgh researchers have developed a new nasal swab test to determine Asthma subtype results for kids. The study which was conducted by Dr. Juan Celedón a ...